Benefits of Partnering with Organizations on System Evaluation
For contract organizations working in the pharmaceutical industry, operating at peak performance and capacity is a vital step towards delivering life-saving therapies.
-
-
Bringing it all together – A modern solution for oligonucleotide analysis
Solving analytical challenges is at the core of our DNA and when it comes to oligonucleotide analysis, we’re at a point now where we can bring together the many advancements we’ve made across the analytical value stream into complete end-to-end workflows that truly deliver best-in-class analytical performance and productivity.
-
The IVDR Cake. We’ve got a slice!
Healthcare Providers and medical device manufacturers alike are working diligently to ensure that their services and products are compliant with these new regulations in the medical device industry in the European Union (EU).
-
Automating Intact Mass Deconvolution: It’s About Time
Waters has been progressing intact mass analyses for an equally long time. Development of the new waters_connect INTACT Mass app was a user-centric process.
-
The Waters Difference: Building Quality into Everything We Do – From A to Z
Waters difference is building quality into every step of the process. Everything we do is focused on making sure our customers receive high quality products, on time.
-
Safeguard HPLC Data Quality with Planned Performance Maintenance
Reproducible, accurate data is critical for making key decisions about your products and obtaining important insights into your research. Learn how to safeguard your data quality by ensuring your HPLC instrument remains consistently in peak condition.
-
Oligonucleotide Manufacturers Keep up with Market Demand using Our Compliance-Ready Instruments
Recent developments in techniques for rapid and efficient oligonucleotide synthesis and molecular biology technology have expanded the market for manufacturers and service providers in the field. Liquid chromatography coupled with mass spectrometry (LC-MS) workflows play a critically important role.
-
Attribute Monitoring Workflows [Infographic]
Learn how the BioAccord LC-MS System is instrumental in the drug development workflow from sample prep to reporting.
-
Modern Perspectives on Method Development
Hear from Dr. Fadi Alkhateeb, a Waters Senior Separations Scientist on the approach and tools used to design and develop fit-for-purpose methods.
-
BioAccord System with ACQUITY Premier: Some Things Work Better Together
Combining BioAccord, our most capable MS detection platform, with ACQUITY Premier UPLC, our highest performance LC system, to demonstrate superior performance.
-
Reliable, Reportable Data with Analytical Quality by Design Approaches
The ways pharmaceutical organizations achieve reliable, reportable data is shifting. We discuss how leveraging modern analytical tools and applying an Analytical Quality by Design approach in your lab can increase the robustness of analytical methods.
-
Biopharma’s Future: Next-Generation LC-MS Workflows for Peptide MAM
The development of biotherapeutics continues to accelerate with their potential to revolutionize disease treatment in areas not adequately addressed by small molecule therapeutics. However, the complexity of these macromolecules and the range of potential modification variants (attributes) creates an interesting analytical challenge for scientists tasked with their characterization and then with monitoring those attributes important…
![Attribute Monitoring Workflows [Infographic]](https://www.waters.com/blog/wp-content/uploads/feature-image-768x758.png)
